This observation made in mice suggests that LPA may also be linked to the damage caused by oxygen deprivation in human fetuses. If that proves to be the case, the research may help scientists and physicians better understand and find new ways to address the numerous developmental disorders that can arise when fetuses are deprived of oxygen in the womb—including mental retardation, epilepsy, schizophrenia, autism, cerebral palsy and a range of other physical and mental problems.
"Fetal brain damage from oxygen deprivation involves specific changes that are, surprisingly, mediated by this lipid signal called LPA," said Scripps Research Professor Jerold Chun, MD, PhD, a member of the Dorris Neuroscience Center who led the research, which appeared in an advance, online issue of the journal Proceedings of the National Academy of Sciences (PNAS) this week.
"Because this pathway can be targeted with drugs," he added, "the discovery suggests that creating new medicines that target LPA receptors may be a way of limiting or preventing serious developmental brain diseases."
Currently, there is no way to treat the neurological damage produced by oxygen deprivation.
How Lack of Oxygen Affects the Fetal Brain
A developing fetus might be temporarily deprived of oxygen—a condition known as “hypoxia”—for any number of reasons, including disruption of blood flow, exposure to smoke, carbon monoxide, or physical trauma.
Physicians have long known that hypoxia can lead to brain damage and increased risk of developmental disorders, and existing public health efforts are aimed at mitigating these risks. Awareness that carbon monoxide from cigarettes can cause hypoxia, for instance, is the major reason why women are warned not to smoke when they are pregnant.
Still, there is a need to find other ways to address the problem, since not every situation in which fetuses might be subjected to oxygen deprivation is preventable. The discovery by Chun, graduate student Keira Herr, and colleagues suggests that there may be a way to mitigate the damage caused by hypoxia directly, by drugs targeting the molecules in the brain that mediates this damage—specifically, the receptor for the phospholipid molecule lysophosphatidic acid (LPA).
Phospholipids, molecules of fat with a charged head on one end, are universally found in biological organisms because they are an essential building block of cellular membranes, defining the boundaries of cells and keeping things inside a cell separated from that which is outside.
But lipids do more than just form barriers. LPA acts as a signal to affect the development of mammalian brains—something that Chun and his colleagues first demonstrated several years ago. His laboratory identified the first cellular receptor to which LPA binds, and they discovered that LPA acts as a signal that influences neurogenesis, the formation of new neurons when fetal brains are developing in the womb, along with the architecture of the brain.
As the brain grows in developing fetuses, it forms specialized regions very quickly. Many of these regions must be up and running by the time a baby is born. Newborns need to be able to breathe, drink, digest, respond to stimuli, and function in countless other basic ways in order to survive.
Problems that arise as the early brain develops may lead to developmental disorders.
Findings that Provide a New Strategy to Block Damage
The prominent role LPA plays in fetal brain development is what led Chun and his colleagues to investigate whether it also played a role in developmental disorders, many of which are believed to be linked to brain disorganization that arises during early development as has been documented in the clinical literature following hypoxic insults.
The team studied the effect of hypoxia in the brains of developing mice and also on brains temporarily grown in Petri dishes. In particular, the researchers studied the changes that occur in young neurons of the cerebral cortex, the part of the brain believed to be involved in higher functions, like memory, cognition, reasoning, and the interpretation of sensory input.
Chun and his colleagues discovered that when hypoxia damages developing cerebral cortical neurons, it does so in very specific ways that require LPA signaling. Scientists had long assumed that the association between hypoxia and brain damage was a non-specific one in which individual neurons all over the brain were randomly killed as a result of being deprived of oxygen.
What Chun and his colleagues found, however, is that hypoxia causes the neurons to become overstimulated, mimicking effects produced by excessive LPA exposure. Genetically removing the receptors for LPA or blocking them through drugs stopped these effects.
Knowing that hypoxia causes brain damage through this LPA signaling pathway provides a strategy to target and block that damage. Blocking LPA signaling may be a new way to prevent damaging changes to the brain and attenuate or prevent diseases linked to hypoxia, a concept that awaits further testing in humans.
The article, "Stereotyped fetal brain disorganization is induced by hypoxia and requires lysophosphatidic acid receptor 1 (LPA ) signaling," (doi: 10.1073/pnas.1106129108) by Keira Joann Herr, Deron R. Herr, Chang-Wook Lee, Kyoko Noguchi, and Jerold Chun appears in the journal PNAS. See: http://dx.doi.org/10.1073/pnas.1106129108
This work was funded primarily by the National Institutes of Health, with fellowship support by the Agency of Science, Technology and Research, Singapore.
About The Scripps Research Institute
The Scripps Research Institute is one of the world's largest independent, non-profit biomedical research organizations. Scripps Research is internationally recognized for its discoveries in immunology, molecular and cellular biology, chemistry, neuroscience, and vaccine development, as well as for its insights into autoimmune, cardiovascular, and infectious disease. Headquartered in La Jolla, California, the institute also includes a campus in Jupiter, Florida, where scientists focus on drug discovery and technology development in addition to basic biomedical science. Scripps Research currently employs about 3,000 scientists, staff, postdoctoral fellows, and graduate students on its two campuses. The institute's graduate program, which awards Ph.D. degrees in biology and chemistry, is ranked among the top ten such programs in the nation. For more information, see www.scripps.edu.For information:
Mika Ono | EurekAlert!
Microscope measures muscle weakness
16.11.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg
Good preparation is half the digestion
16.11.2018 | Max-Planck-Institut für Stoffwechselforschung
Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.
Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...
Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.
Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...
Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.
In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...
On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.
When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure
Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...
09.11.2018 | Event News
06.11.2018 | Event News
23.10.2018 | Event News
16.11.2018 | Health and Medicine
16.11.2018 | Life Sciences
16.11.2018 | Life Sciences